We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+16.9%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$13.2M
Cap. Flow
+$877K
Cap. Flow %
0.69%
Top 10 Hldgs %
43.94%
Holding
59
New
7
Increased
24
Reduced
19
Closed
7

Top Buys

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$1.91M
2
TSRO
TESARO, Inc.
TSRO
+$1.8M
3
RXDX
Ignyta, Inc.
RXDX
+$1.76M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.76M
5
BKR icon
Baker Hughes
BKR
+$1.7M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$2.74M
2
NXTM
NxStage Medical Inc.
NXTM
+$1.8M
3
AWI icon
Armstrong World Industries
AWI
+$1.65M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.58M
5
AXTA icon
Axalta
AXTA
+$1.58M

Sector Composition

Rank Sector Weight
1 Healthcare 46.68%
2 Financials 30.76%
3 Technology 5.34%
4 Consumer Discretionary 5.22%
5 Energy 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBRE icon
26
CBRE Group
CBRE
$41.3B
$1.73M 1.37%
45,642
-47
-0.1% -$1.73K
AVXS
27
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.73M 1.37%
17,867
-4,883
-21% -$440K
MS icon
28
Morgan Stanley
MS
$339B
$1.73M 1.37%
35,817
-1,731
-5% -$80.3K
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$1.72M 1.36%
12,283
-1,324
-10% -$180K
GHDX
30
DELISTED
Genomic Health, Inc.
GHDX
$1.72M 1.36%
53,439
+980
+2% +$30.9K
ESPR
31
DELISTED
Esperion Therapeutics
ESPR
$1.7M 1.35%
33,975
-12,791
-27% -$617K
QVCGA
32
DELISTED
QVC Group Inc Series A
QVCGA
$1.7M 1.34%
+1,485
New +$1.67M
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
$1.7M 1.34%
26,837
+1,237
+5% +$76.9K
MSFT icon
34
Microsoft
MSFT
$2.93T
$1.7M 1.34%
22,778
-461
-2% -$33.7K
VSAT icon
35
Viasat
VSAT
$9.76B
$1.7M 1.34%
26,368
+2,413
+10% +$153K
ACGL icon
36
Arch Capital
ACGL
$35.4B
$1.68M 1.33%
51,066
+2,184
+4% +$70.5K
STX icon
37
Seagate
STX
$178B
$1.68M 1.33%
50,550
+13,977
+38% +$475K
WTW icon
38
Willis Towers Watson
WTW
$27.7B
$1.68M 1.33%
10,874
-167
-2% -$24.9K
VISN
39
Vistance Networks Inc
VISN
$2.74B
$1.68M 1.33%
50,472
+9,152
+22% +$313K
KMI icon
40
Kinder Morgan
KMI
$71.9B
$1.66M 1.31%
86,463
+7,006
+9% +$136K
BFH icon
41
Bread Financial
BFH
$4.01B
$1.64M 1.3%
9,270
+1,064
+13% +$197K
RARX
42
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.64M 1.29%
112,084
+48,940
+78% +$740K
DBVT
43
DBV Technologies
DBVT
$870M
$1.63M 1.29%
3,838
-601
-14% -$258K
LEXEA
44
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$1.63M 1.29%
30,640
+478
+2% +$25.9K
BIVV
45
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1.62M 1.28%
28,418
-399
-1% -$23.4K
AKAO
46
DELISTED
Achaogen Inc
AKAO
$1.61M 1.27%
100,821
+36,308
+56% +$691K
LSXMK
47
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.59M 1.26%
49,800
-2,929
-6% -$95.3K
TFCF
48
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$1.53M 1.21%
59,251
+1,698
+3% +$46.1K
LVNTA
49
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$1.53M 1.21%
26,547
-3,609
-12% -$209K
INCY icon
50
Incyte
INCY
$23.4B
$1.52M 1.2%
13,030
+1,460
+13% +$185K
1
2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q3 2017 Portfolio in Review

As of Q3 2017, Emory University held 59 positions worth $126M, up 12% from $113M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Emory University's Q3 2017 filing shows 7 new, 24 increased, 19 reduced and 7 closed positions. Its largest new stake was Puma Biotechnology: 20,555 shares worth $2.46M. The largest sale was Loxo Oncology, Inc, an estimated $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 44% a quarter earlier, followed by Financials and Technology.

  • Emory University's largest Q3 2017 buy was Puma Biotechnology: 20,555 shares worth $2.46M.
  • Emory University added most to Ra Pharmaceuticals, Inc. Common Stock in Q3 2017, an estimated $740K increase.
  • Emory University's biggest Q3 2017 reduction was BeOne Medicines Ltd, cutting an estimated $1.36M.
  • Emory University fully exited Loxo Oncology, Inc in Q3 2017, selling an estimated $2.74M.
  • Emory University's ten largest holdings make up 44% of its $126M portfolio in Q3 2017.
  • Emory University opened 7 new positions and closed 7 in Q3 2017.
  • Emory University's portfolio value rose 12% quarter-over-quarter to $126M.

Based on Emory University's 13F filing for Q3 2017, filed 14 Nov 2017.